A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

NCT02760264 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: Vamorolone 0.25 mg/kg/day
DRUG: Vamorolone 0.75 mg/kg/day
DRUG: Vamorolone 2.0 mg/kg/day
DRUG: Vamorolone 6.0 mg/kg/day

Sponsor

ReveraGen BioPharma, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]